生分解性ポリマービーヅを用いた経口免疫法の開発と経口免疫寛容の解析への応用
生分解性ポリマービーヅを用いた経口免疫法の開発と経口免疫寛容の解析への応用
批准号:
09557047
负责人:
WAKATSUKI Yoshio
金额:
$3.39万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Oral immunization of antigens has long been recognized as a method to prevent or delay the onset of the diseases associated with untoward immune responses to self and non-self antigens. Although oral administration of antigens offers a convenient way to induce systemictolerance, its therapeutic potential has been seriously limited by the fact that it requires repeated feeding of a large amount of antigens and that it may deteriorate ongoing autoimmune diseases when autoantigens are employed. We have previously shown that orally administered poly-D,L-lactic accid (PDLLA) microspheres containing an antigen were selectively distributed to Peyer's patches (PP) and systemic-lymphoid tissues according to their diameter and then releses the antigen over a long period of time. We reported that a single dose of intragastric imunization with a PDLLA microsphere of appropropriate diameter size containing 2 mg of OVA was as effective as 100 mg of water soluble OVA to suppress OVA-specific IgG ad DTH response. This was associated with a large incresae of IFN-g production by PP T cells stimulated with an antigen and a small increase in secretory IgA specific to OVA. In contrast, administration of an antigen encapsulatead in another appropriate diameter size led to an enhanced OVA-specific IgG response and no significant increase in OVA-specific secretory IgA. Thus, by utilizing microspheres of an appropriate diameter as a vaccination vehicle, we were able to selectively induce both systemic tolerance and sensitization by oral ingestion of single low dose of an antigen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yoichi Matsunaga, Yoshio Wakatsuki, et al: "Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization"Vaccine. Sept. (in press). (2000)
Yoichi Matsunaga、Yoshio Wakatsuki 等人:“以尺寸纯化的微球珠作为载体的口服免疫可选择性诱导全身耐受和致敏”疫苗。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kweon NM,Fujihashi K,Wakatuki Y et al: "Mucosally Induced Systemic T Cell Unresponsiveness to Ovalbumin requires CD40 Ligand-CD40 IO Interactions" Journal of Immunology. 162. 1904-1909 (1999)
Kweon NM、Fujihashi K、Wakatuki Y 等人:“粘膜诱导的系统性 T 细胞对卵清蛋白无反应需要 CD40 配体-CD40 IO 相互作用”免疫学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kweon, M. N., Fujihashi, K., Wakatsuki, Y. et.al: "Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions"J Immunol. 162(4). 1904-9 (1999)
Kweon, M. N.、Fujihashi, K.、Wakatsuki, Y. 等人:“粘膜诱导的全身性 T 细胞对卵清蛋白无反应需要 CD40 配体-CD40 相互作用”J 免疫学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Usui, T., Wakatsuki, Y., et.al: "Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype"J Immunol. 158(7). 3197-2041 (1997)
Usui, T.、Wakatsuki, Y. 等人:“晚期 B 细胞中 B 细胞特异性激活蛋白 (BSAP/Pax-5) 的过度表达足以抑制分化为具有浆细胞表型的 Ig 高生产细胞
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Sakata-Kaneko,Y.Wakatsuki et al: "Altered Th1/Th2 Commitment in Human CD4 T cells With Aging"Clin Exp Immunology. (in press). (2000)
S.Sakata-Kaneko、Y.Wakatsuki 等人:“随着衰老,人类 CD4 T 细胞的 Th1/Th2 承诺发生改变”Clin Exp 免疫学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 20 条
Studies on host factors determining prognosis and pathophysiology of patients with Helicobacter pylori infection
-
批准号:14370180
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.31万
-
财政年份:2002
-
负责人:WAKATSUKI Yoshio
-
依托单位:
Studies on the host related factors determining clinical manifestation of the Helicobacter pylori infection among patients with various ethnic backgrounds.
-
批准号:11691206
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.74万
-
财政年份:1999
-
负责人:WAKATSUKI Yoshio
-
依托单位:
B細胞終末分化の分子機構についての研究
-
批准号:09836006
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1997
-
负责人:WAKATSUKI Yoshio
-
依托单位:
海外基金